InvestorsHub Logo

ShortsRClowns

05/27/21 1:56 PM

#127522 RE: OR Nurse #127519

That seems highly unlikely since milestone 19, listed below, is going to occur between Q2-Q4 2022. A year + away. So FDA late 2022 or early 2023 if all stays on track per their development table.

Milestone 16

Complete IDE clinical study, data analysis and final report

https://ih.advfn.com/stock-market/NASDAQ/titan-medical-TMDI/stock-news/84619819/post-effective-amendment-to-registration-statement

DiceMaker

05/27/21 2:03 PM

#127523 RE: OR Nurse #127519

Now that they have IDE approval, they need to complete the investigation and request market approval. I think the timing for that may align with milestone 4, but not certain.